Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1219019-02-9

Post Buying Request

1219019-02-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1219019-02-9 Usage

General Description

2-(3,3-difluorocyclobutyl)acetonitrile is a chemical compound with the molecular formula C6H7F2N. It is a colorless liquid with a faint odor, and it is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 2-(3,3-difluorocyclobutyl)acetonitrile is known for its stability and low reactivity, making it a valuable building block for the production of other chemical compounds. Additionally, 2-(3,3-difluorocyclobutyl)acetonitrile has potential applications in the development of new materials, such as polymers and specialty chemicals. However, it is important to handle this chemical with caution due to its toxic and flammable nature.

Check Digit Verification of cas no

The CAS Registry Mumber 1219019-02-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,9,0,1 and 9 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1219019-02:
(9*1)+(8*2)+(7*1)+(6*9)+(5*0)+(4*1)+(3*9)+(2*0)+(1*2)=119
119 % 10 = 9
So 1219019-02-9 is a valid CAS Registry Number.

1219019-02-9Relevant articles and documents

BICYCLIC JAK INHIBITORS AND USES THEREOF

-

, (2020/10/20)

Provided herein are compounds of Formulas (I), (II), (III), and (IV) and subformulas thereof, wherein the variables are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I), (II), (III), or (IV) and methods of using the compounds, e.g., in the treatment of immune disorders, inflammatory disorders, and cancer.

SOLUBLE GUANYLATE CYCLASE ACTIVATORS

-

, (2015/06/25)

A compound of Formula I or a pharmaceutically acceptable salt thereof, are capable of modulating the body's production of cyclic guanosine monophosphate (" cGMP") and are generally suitable for the therapy and prophylaxis of diseases which are associated with a disturbed cGMP balance. The invention furthermore relates to processes for preparing compounds of Formula I, or a pharmaceuticall acceptable salt thereof, for their use in the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical preparations which comprise compounds of Formula I or a pharmaceutically acceptable salt thereof.

NOVEL COMPOUNDS

-

Page/Page column 46, (2015/12/17)

Disclosed are novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1219019-02-9